Are you dealing with facial redness? Are you tired of camouflaging the redness with makeup, working hard to conceal instead of treating your skin condition? You might be have a condition known as Rosacea.
Rosacea is a common skin condition that affects an estimated 16 million Americans. Facial redness is the most widely experienced rosacea symptom, and, according to the National Rosacea Society, may be the only symptom many people will experience.
Galderma Laboratories L.P., which makes Mirvaso® (brimonidine) topical gel, 0.33%,* the first and only FDA-approved treatment specifically developed and indicated for the persistent facial redness of rosacea.
Mirvaso has launched their Break Up with Your Makeup campaign which helps promote an awareness program with an online resource designed to help women understand that they can finally TREAT, and stop CONCEALING with makeup, their rosacea redness – and will also provide you with a chance to win a trip to the Emmys.
Break Up with Your Makeup helps real women confront their facial redness and soothe, and treat the redness associated with Rosacea.
Important Safety InformationIndication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.
Full Disclosure: Winner must be 18 years or older and a US Resident. No purchase necessary. Winners will be notified via email with the specifics on how to claim their prize. Contest ends August 21, 2014 at Midnight EST. Winners will be picked by random.org. By entering this contest, you will automatically be signing up for the Momtrends newsletter. This is a sponsored post.